HYZAAR

This brand name is authorized in Brazil, Canada, Ecuador, France, Hong Kong, Croatia, Mexico, Netherlands, Poland, Singapore, Turkey, United States

Active ingredients

The drug HYZAAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Losartan UNII 3ST302B24A - LOSARTAN POTASSIUM

Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade. Read about Losartan

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HYZAAR Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA01	Losartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525501201111319, 525501202118317, 525512070015103, 525512070015203
Country: CA	Health Products and Food Branch	Identifier(s): 02230047, 02241007, 02297841
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29375-1-09-10, 29410-10-10, 366200613
Country: FR	Base de données publique des médicaments	Identifier(s): 64539188
Country: HK	Department of Health Drug Office	Identifier(s): 41895, 49317, 55223
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-667284558, HR-H-883944358
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 360M95
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 69299
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100088470, 100111392, 100255820
Country: SG	Health Sciences Authority	Identifier(s): 09429P, 11462P, 13419P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337213, 8683280337220, 8683280337237, 8683280337244, 8683280337251, 8683280337268
Country: US	FDA, National Drug Code	Identifier(s): 0006-0717, 0006-0745, 0006-0747, 55289-522, 63629-3183